Back to company

Boehringer Ingelheim Animal Health Denmark A/S: Financial statements 2022

CVR: 13526990

Boehringer Ingelheim Animal Health Denmark A/S (CVR 13526990) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 587,463,000 and a net result of DKK 17,459,000 compared with DKK 25,014,000 the year before. That is a decrease of 0.2% compared with the year before. The profit margin was 3%. Equity amounted to DKK 93,983,000. The solvency ratio was 29.3%. The company had 96 employees in the financial year.

Revenue
587,463,000 kr.
Gross Profit
105,268,000 kr.
Profit/Loss
17,459,000 kr.
Equity
93,983,000 kr.
Total Assets
320,979,000 kr.
Employees
96

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022587.5 mio.105.3 mio.17.5 mio.94 mio.96
2021588.5 mio.111.4 mio.25 mio.77.1 mio.103
2020622.6 mio.147.7 mio.51.2 mio.98.2 mio.109
2019596.5 mio.100.4 mio.-21.1 mio.46.7 mio.112
2018573.7 mio.109.7 mio.7.6 mio.70.5 mio.114

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Boehringer Ingelheim Animal Health Denmark A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Niko Rodio joins the board of Boehringer Ingelheim Animal Health Denmark A/SJun 16, 2022

As of June 16, 2022, Niko Rodio has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.

Stephen Mark Wright joins the board of Boehringer Ingelheim Animal Health Denmark A/SJun 16, 2022

As of June 16, 2022, Stephen Mark Wright has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.

Nicolas Charles Dumoulin leaves the board of Boehringer Ingelheim Animal Health Denmark A/SJun 16, 2022

As of June 16, 2022, Nicolas Charles Dumoulin has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.

Niko Rodio leaves the board of Boehringer Ingelheim Animal Health Denmark A/SJun 15, 2022

As of June 15, 2022, Niko Rodio has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.

Boehringer Ingelheim Animal Health Denmark A/S: The 2021 annual report is outJun 8, 2022

Boehringer Ingelheim Animal Health Denmark A/S has published its annual report for 2021. Revenue came to DKK 588,519,000, and the net result was DKK 25,014,000.

About Boehringer Ingelheim Animal Health Denmark A/S

Boehringer Ingelheim Animal Health Denmark A/S is a Danish company of the type Aktieselskab based in København S, founded in 1989. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named MERIAL NORDEN A/S and RHONE MERIEUX NORDEN A/S. The management consists of Dirk Neven Rauleder. The company is owned by Boehringer Ingelheim Animal Health International GmbH. The company has 95 employees. In 2025, the company reported revenue of DKK 725,936,000 and a net result of DKK -3,950,000 compared with DKK 40,407,000 the year before. Equity amounted to DKK 90,111,000.